Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Small Extracellular Vesicles for Severe and Profound Sudden Sensorineural Hearing Loss
NCT07404709Phase 2Not yet recruiting
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Feb 2026
- Primary completion
- Dec 2027
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of hUC-MSC-sEV-003 in sudden sensorineural hearing loss (SSHL), sponsored by The Affiliated Hospital of Qingdao University. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
hUC-MSC-sEV-003
03
Conditions
sudden sensorineural hearing loss (SSHL)
Beyond the preview
Go deeper on NCT07404709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07404709.